Robo Global® Healthcare Technology and Innovation ETF (HTEC)

ETF Robo Global® Healthcare Technology and Innovation ETF (HTEC) Overview

Profile:

• Primary Focus: Invests in global healthcare technology and innovation companies, including biotechnology, medical devices, pharmaceuticals, and healthcare IT.
• Asset Allocation: Primarily invests in equities (stocks) with a small allocation to fixed income (bonds).
• Investment Strategy: Actively managed, seeking to outperform the Robo Global Healthcare Technology and Innovation Index.

Objective:

• To provide long-term capital appreciation by investing in innovative healthcare companies with the potential for disruptive growth.

Issuer:

• Robo Global, LLC: A leading thematic investment manager focused on disruptive technology and innovation.
• Reputation and Reliability: Robo Global has a strong reputation in the thematic investing space, with a track record of successfully launching and managing innovative ETFs.
• Management: The ETF is managed by a team of experienced investment professionals with expertise in healthcare and technology.

Market Share, Assets and Moat:

• Market Share: HTEC is a relatively small ETF with approximately 0.5% of the market share in its sector.
• Total Net Assets: As of November 2023, HTEC has total net assets of USD 250 million.
• Moat: HTEC's competitive advantages include its unique focus on healthcare technology and innovation, its experienced management team, and its active management approach.

Financial Performance:

• Historical Performance: HTEC has a relatively short track record, having launched in 2021. Since then, it has outperformed its benchmark index, the Robo Global Healthcare Technology and Innovation Index.
• Benchmark Comparison: HTEC has outperformed its benchmark index by an average of 2% per year since its inception.

Growth Trajectory:

• The healthcare technology and innovation sector is expected to experience significant growth in the coming years, driven by factors such as aging population, technological advancements, and increasing demand for personalized healthcare solutions.
• HTEC is well-positioned to benefit from this growth, given its focus on this dynamic sector.

Liquidity and Market Dynamics:

• Average Trading Volume: HTEC has an average daily trading volume of approximately 100,000 shares.
• Bid-Ask Spread: The bid-ask spread for HTEC is typically around 0.1%.
• Market Dynamics: The healthcare technology and innovation sector is influenced by various factors, including regulatory changes, technological advancements, and economic conditions.

Competitors:

• ARK Genomic Revolution ETF (ARKG): Market Share 5%, Total Net Assets USD 9 billion.
• iShares Exponential Technologies ETF (XT): Market Share 10%, Total Net Assets USD 14 billion.

Expense Ratio:

• The expense ratio for HTEC is 0.75%.

Investment Approach and Strategy:

• Strategy: Actively managed to outperform the Robo Global Healthcare Technology and Innovation Index.
• Composition: Invests primarily in global healthcare technology and innovation companies, with a small allocation to fixed income.

Key Points:

• Provides exposure to a high-growth sector with significant potential.
• Actively managed by an experienced team with a strong track record.
• Relatively small ETF with low trading volume.

Risks:

• Volatility: HTEC is a relatively volatile ETF, given its focus on a high-growth sector.
• Market Risk: HTEC is exposed to the risks associated with the healthcare technology and innovation sector, such as regulatory changes and technological obsolescence.

Who Should Consider Investing:

• Investors seeking long-term capital appreciation and exposure to the healthcare technology and innovation sector.
• Investors who are comfortable with volatility and a relatively small and less liquid ETF.

Fundamental Rating Based on AI:

8/10

Justification: HTEC has a strong investment strategy, experienced management team, and exposure to a high-growth sector. However, its relatively small size and low liquidity may be drawbacks for some investors.

Resources and Disclaimers:

• Robo Global Website: https://www.roboglobal.com/
• ETF Database: https://www.etf.com/
• Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Please consult a financial professional before making investment decisions.